A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT05039099 · COMPLETED
Trial details
- NCT number
- NCT05039099
- Sponsor
- AL-S Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2025-08-13
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.